On June 3-4, as a part St. Petersburg International Economic Forum 2021 (SPIEF'21), Pharmasyntez, JSC and a number of key regions of the Russian Federation are planning to enter into an Agreement of Intent to attract investments in the construction of new manufacturing sites of the Pharmasyntez Group of Companies. Thus, the Company continues to pursue its policy on filling its product portfolio with drugs for the treatment of socially significant diseases.

The Pharmasyntez Group of Companies is one of the leading pharmaceutical manufacturers in the hospital procurement segment and a reliable participant in the Russian healthcare system.

To get the SPIEF'21 business program, please, visit the event website https://forumspb.com/programme/business-programme/.